North America Enzymatic Wound Debridement Market Size, Share & Trends Analysis Report By End-use, By Type (Chronic Wounds and Acute Wounds), By Product (Collagenase Product, Papain Product, and Others), By Country and Growth Forecast, 2023

List of Tables

The North America Enzymatic Wound Debridement Market would witness market growth of 5.3% CAGR during the forecast period (2023-2030).

Papain and collagenase-based products treat pressure ulcers, diabetic foot, and venous limb ulcers. The main use of collagenase-based enzymatic wound debridement products is the treatment of surgical wounds. Surgical incisions following cancer surgery are frequently substantial and profound, generating exudate that necessitates constant removal. When treated with the right medicines, large wounds are substantially less susceptible to infection. Consequently, the increasing prevalence of chronic illnesses is expected to stimulate market expansion by bolstering the demand for these products.

Researchers are undertaking various initiatives, and key players are developing technologically advanced products owing to the rising demand for these products regionally, which is anticipated to boost market growth. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. For instance, NexoBrid (NXB), previously referred to as Debriding Gel Dressing (DGD)-derived from the pineapple Bromelain group of enzymes-was introduced in 2017. NXB is an enzymatic wound-debriding drug that can effectively treat deep burn wounds.

North America has a large and aging population, leading to an increased incidence of wounds associated with age-related conditions. The Centers for Disease Control and Prevention report that the number of obesities in the United States rose from 30.5% to 41.9% between 1999-2000 and 2017-March 2020. Concurrently, the majority of chronic obesity increased from 4.7% to 9.2%. Obesity is a major risk factor for conditions such as diabetes, peripheral vascular disease, and venous lack, which can lead to the development of chronic wounds. Diabetic foot ulcers are more prevalent in individuals with obesity. As the obesity rates grow, so does the occurrence of wounds that require specialized care. As a result, these aspects will boost the market growth in the coming years.

The US market dominated the North America Enzymatic Wound Debridement Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $384.9 million by 2030. The Canada market is experiencing a CAGR of 7.7% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 6.8% during (2023 - 2030).

Based on End-use, the market is segmented into Hospitals, Homecare, and Others. Based on Type, the market is segmented into Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others), and Acute Wounds (Burns, and Others). Based on Product, the market is segmented into Collagenase Product, Papain Product, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ConvaTec Group PLC, Smith & Nephew PLC, Molnlycke Health Care AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., 3M Company, HARTMANN Group (Paul Hartmann AG) and MediWound Ltd

Scope of the Study

Market Segments covered in the Report:

By End-use

Hospitals
Homecare
Others

By Type

Chronic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Others
Acute Wounds
- Burns
- Others

By Product

Collagenase Product
Papain Product
Others

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

ConvaTec Group PLC
Smith & Nephew PLC
Molnlycke Health Care AB
Integra LifeSciences Holdings Corporation
B. Braun Melsungen AG
Coloplast Group
Medline Industries, Inc.
3M Company
HARTMANN Group (Paul Hartmann AG)
MediWound Ltd

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Enzymatic Wound Debridement Market, by End-use
- 1.4.2 North America Enzymatic Wound Debridement Market, by Type
- 1.4.3 North America Enzymatic Wound Debridement Market, by Product
- 1.4.4 North America Enzymatic Wound Debridement Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Forces Analysis

Chapter 4. North America Enzymatic Wound Debridement Market by End-use

4.1 North America Hospitals Market by Country
4.2 North America Homecare Market by Country
4.3 North America Others Market by Country

Chapter 5. North America Enzymatic Wound Debridement Market by Type

5.1 North America Chronic Wounds Market by Region
5.2 North America Enzymatic Wound Debridement Market by Chronic Wounds Type
- 5.2.1 North America Diabetic Foot Ulcers Market by Country
- 5.2.2 North America Pressure Ulcers Market by Country
- 5.2.3 North America Venous Leg Ulcers Market by Country
- 5.2.4 North America Others Market by Country
5.3 North America Acute Wounds Market by Region
5.4 North America Enzymatic Wound Debridement Market by Acute Wounds Type
- 5.4.1 North America Burns Market by Country
- 5.4.2 North America Others Market by Country

Chapter 6. North America Enzymatic Wound Debridement Market by Product

6.1 North America Collagenase Product Market by Country
6.2 North America Papain Product Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Enzymatic Wound Debridement Market by Country

7.1 US Enzymatic Wound Debridement Market
- 7.1.1 US Enzymatic Wound Debridement Market by End-use
- 7.1.2 US Enzymatic Wound Debridement Market by Type
  - 7.1.2.1 US Enzymatic Wound Debridement Market by Chronic Wounds Type
  - 7.1.2.2 US Enzymatic Wound Debridement Market by Acute Wounds Type
- 7.1.3 US Enzymatic Wound Debridement Market by Product
7.2 Canada Enzymatic Wound Debridement Market
- 7.2.1 Canada Enzymatic Wound Debridement Market by End-use
- 7.2.2 Canada Enzymatic Wound Debridement Market by Type
  - 7.2.2.1 Canada Enzymatic Wound Debridement Market by Chronic Wounds Type
  - 7.2.2.2 Canada Enzymatic Wound Debridement Market by Acute Wounds Type
- 7.2.3 Canada Enzymatic Wound Debridement Market by Product
7.3 Mexico Enzymatic Wound Debridement Market
- 7.3.1 Mexico Enzymatic Wound Debridement Market by End-use
- 7.3.2 Mexico Enzymatic Wound Debridement Market by Type
  - 7.3.2.1 Mexico Enzymatic Wound Debridement Market by Chronic Wounds Type
  - 7.3.2.2 Mexico Enzymatic Wound Debridement Market by Acute Wounds Type
- 7.3.3 Mexico Enzymatic Wound Debridement Market by Product
7.4 Rest of North America Enzymatic Wound Debridement Market
- 7.4.1 Rest of North America Enzymatic Wound Debridement Market by End-use
- 7.4.2 Rest of North America Enzymatic Wound Debridement Market by Type
  - 7.4.2.1 Rest of North America Enzymatic Wound Debridement Market by Chronic Wounds Type
  - 7.4.2.2 Rest of North America Enzymatic Wound Debridement Market by Acute Wounds Type
- 7.4.3 Rest of North America Enzymatic Wound Debridement Market by Product

Chapter 8. Company Profiles

8.1 ConvaTec Group PLC
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 SWOT Analysis
8.2 Smith & Nephew PLC
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional and Segmental Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
8.3 Molnlycke Health Care AB
- 8.3.1 Company Overview
- 8.3.2 SWOT Analysis
8.4 Integra LifeSciences Holdings Corporation
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Acquisition and Mergers:
- 8.4.6 SWOT Analysis
8.5 B. Braun Melsungen AG
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
8.6 Coloplast Group
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 SWOT Analysis
8.7 Medline Industries, LP
- 8.7.1 Company Overview
- 8.7.2 Recent strategies and developments:
  - 8.7.2.1 Partnerships, Collaborations, and Agreements:
  - 8.7.2.2 Approvals:
- 8.7.3 SWOT Analysis
8.8 3M Company
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 SWOT Analysis
8.9 HARTMANN Group (Paul Hartmann AG)
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expenses
- 8.9.5 SWOT Analysis
8.10. MediWound Ltd
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Research & Development Expenses
- 8.10.4 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Enzymatic Wound Debridement Market, 2019 - 2022, USD Million
TABLE 2 North America Enzymatic Wound Debridement Market, 2023 - 2030, USD Million
TABLE 3 North America Enzymatic Wound Debridement Market by End-use, 2019 - 2022, USD Million
TABLE 4 North America Enzymatic Wound Debridement Market by End-use, 2023 - 2030, USD Million
TABLE 5 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Homecare Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Homecare Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Enzymatic Wound Debridement Market by Type, 2019 - 2022, USD Million
TABLE 12 North America Enzymatic Wound Debridement Market by Type, 2023 - 2030, USD Million
TABLE 13 North America Chronic Wounds Market by Region, 2019 - 2022, USD Million
TABLE 14 North America Chronic Wounds Market by Region, 2023 - 2030, USD Million
TABLE 15 North America Enzymatic Wound Debridement Market by Chronic Wounds Type, 2019 - 2022, USD Million
TABLE 16 North America Enzymatic Wound Debridement Market by Chronic Wounds Type, 2023 - 2030, USD Million
TABLE 17 North America Diabetic Foot Ulcers Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Diabetic Foot Ulcers Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Pressure Ulcers Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Pressure Ulcers Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Venous Leg Ulcers Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Venous Leg Ulcers Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Acute Wounds Market by Region, 2019 - 2022, USD Million
TABLE 26 North America Acute Wounds Market by Region, 2023 - 2030, USD Million
TABLE 27 North America Enzymatic Wound Debridement Market by Acute Wounds Type, 2019 - 2022, USD Million
TABLE 28 North America Enzymatic Wound Debridement Market by Acute Wounds Type, 2023 - 2030, USD Million
TABLE 29 North America Burns Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Burns Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 33 North America Enzymatic Wound Debridement Market by Product, 2019 - 2022, USD Million
TABLE 34 North America Enzymatic Wound Debridement Market by Product, 2023 - 2030, USD Million
TABLE 35 North America Collagenase Product Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Collagenase Product Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Papain Product Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Papain Product Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Enzymatic Wound Debridement Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Enzymatic Wound Debridement Market by Country, 2023 - 2030, USD Million
TABLE 43 US Enzymatic Wound Debridement Market, 2019 - 2022, USD Million
TABLE 44 US Enzymatic Wound Debridement Market, 2023 - 2030, USD Million
TABLE 45 US Enzymatic Wound Debridement Market by End-use, 2019 - 2022, USD Million
TABLE 46 US Enzymatic Wound Debridement Market by End-use, 2023 - 2030, USD Million
TABLE 47 US Enzymatic Wound Debridement Market by Type, 2019 - 2022, USD Million
TABLE 48 US Enzymatic Wound Debridement Market by Type, 2023 - 2030, USD Million
TABLE 49 US Enzymatic Wound Debridement Market by Chronic Wounds Type, 2019 - 2022, USD Million
TABLE 50 US Enzymatic Wound Debridement Market by Chronic Wounds Type, 2023 - 2030, USD Million
TABLE 51 US Enzymatic Wound Debridement Market by Acute Wounds Type, 2019 - 2022, USD Million
TABLE 52 US Enzymatic Wound Debridement Market by Acute Wounds Type, 2023 - 2030, USD Million
TABLE 53 US Enzymatic Wound Debridement Market by Product, 2019 - 2022, USD Million
TABLE 54 US Enzymatic Wound Debridement Market by Product, 2023 - 2030, USD Million
TABLE 55 Canada Enzymatic Wound Debridement Market, 2019 - 2022, USD Million
TABLE 56 Canada Enzymatic Wound Debridement Market, 2023 - 2030, USD Million
TABLE 57 Canada Enzymatic Wound Debridement Market by End-use, 2019 - 2022, USD Million
TABLE 58 Canada Enzymatic Wound Debridement Market by End-use, 2023 - 2030, USD Million
TABLE 59 Canada Enzymatic Wound Debridement Market by Type, 2019 - 2022, USD Million
TABLE 60 Canada Enzymatic Wound Debridement Market by Type, 2023 - 2030, USD Million
TABLE 61 Canada Enzymatic Wound Debridement Market by Chronic Wounds Type, 2019 - 2022, USD Million
TABLE 62 Canada Enzymatic Wound Debridement Market by Chronic Wounds Type, 2023 - 2030, USD Million
TABLE 63 Canada Enzymatic Wound Debridement Market by Acute Wounds Type, 2019 - 2022, USD Million
TABLE 64 Canada Enzymatic Wound Debridement Market by Acute Wounds Type, 2023 - 2030, USD Million
TABLE 65 Canada Enzymatic Wound Debridement Market by Product, 2019 - 2022, USD Million
TABLE 66 Canada Enzymatic Wound Debridement Market by Product, 2023 - 2030, USD Million
TABLE 67 Mexico Enzymatic Wound Debridement Market, 2019 - 2022, USD Million
TABLE 68 Mexico Enzymatic Wound Debridement Market, 2023 - 2030, USD Million
TABLE 69 Mexico Enzymatic Wound Debridement Market by End-use, 2019 - 2022, USD Million
TABLE 70 Mexico Enzymatic Wound Debridement Market by End-use, 2023 - 2030, USD Million
TABLE 71 Mexico Enzymatic Wound Debridement Market by Type, 2019 - 2022, USD Million
TABLE 72 Mexico Enzymatic Wound Debridement Market by Type, 2023 - 2030, USD Million
TABLE 73 Mexico Enzymatic Wound Debridement Market by Chronic Wounds Type, 2019 - 2022, USD Million
TABLE 74 Mexico Enzymatic Wound Debridement Market by Chronic Wounds Type, 2023 - 2030, USD Million
TABLE 75 Mexico Enzymatic Wound Debridement Market by Acute Wounds Type, 2019 - 2022, USD Million
TABLE 76 Mexico Enzymatic Wound Debridement Market by Acute Wounds Type, 2023 - 2030, USD Million
TABLE 77 Mexico Enzymatic Wound Debridement Market by Product, 2019 - 2022, USD Million
TABLE 78 Mexico Enzymatic Wound Debridement Market by Product, 2023 - 2030, USD Million
TABLE 79 Rest of North America Enzymatic Wound Debridement Market, 2019 - 2022, USD Million
TABLE 80 Rest of North America Enzymatic Wound Debridement Market, 2023 - 2030, USD Million
TABLE 81 Rest of North America Enzymatic Wound Debridement Market by End-use, 2019 - 2022, USD Million
TABLE 82 Rest of North America Enzymatic Wound Debridement Market by End-use, 2023 - 2030, USD Million
TABLE 83 Rest of North America Enzymatic Wound Debridement Market by Type, 2019 - 2022, USD Million
TABLE 84 Rest of North America Enzymatic Wound Debridement Market by Type, 2023 - 2030, USD Million
TABLE 85 Rest of North America Enzymatic Wound Debridement Market by Chronic Wounds Type, 2019 - 2022, USD Million
TABLE 86 Rest of North America Enzymatic Wound Debridement Market by Chronic Wounds Type, 2023 - 2030, USD Million
TABLE 87 Rest of North America Enzymatic Wound Debridement Market by Acute Wounds Type, 2019 - 2022, USD Million
TABLE 88 Rest of North America Enzymatic Wound Debridement Market by Acute Wounds Type, 2023 - 2030, USD Million
TABLE 89 Rest of North America Enzymatic Wound Debridement Market by Product, 2019 - 2022, USD Million
TABLE 90 Rest of North America Enzymatic Wound Debridement Market by Product, 2023 - 2030, USD Million
TABLE 91 Key Information - ConvaTec Group PLC
TABLE 92 Key Information - Smith & Nephew PLC
TABLE 93 Key Information - Molnlycke Health Care AB
TABLE 94 Key Information - Integra LifeSciences Holdings Corporation
TABLE 95 Key Information - B. Braun Melsungen AG
TABLE 96 key Information - Coloplast Group
TABLE 97 Key Information - Medline Industries, Lp
TABLE 98 Key Information - 3M Company
TABLE 99 Key Information - HARTMANN Group
TABLE 100 Key Information - MediWound Ltd

North America Enzymatic Wound Debridement Market Size, Share & Trends Analysis Report By End-use, By Type (Chronic Wounds and Acute Wounds), By Product (Collagenase Product, Papain Product, and Others), By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents